Floxin Otic Related Published Studies
Well-designed clinical trials related to Floxin Otic (Ofloxacin Otic)
Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea. [2006.12]
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. [2004.06]
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. [2004.01]
Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. [2001.01]
Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation. [2000.01]
Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes. [1998.11.15]
Ofloxacin otic solution for treatment of otitis externa in children and adults. [1997.11]
A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media. [1996.04]
Well-designed clinical trials possibly related to Floxin Otic (Ofloxacin Otic)
Assessing the efficacy of tragal pumping: a randomized controlled trial. [2011.06]
Other research related to Floxin Otic (Ofloxacin Otic)
Comparison of systemic and otic administration of ofloxacin. [2010.10]
Safety of ofloxacin (OFLX) and fosfomycin sodium (FOM) ear drops. [2007.06]
Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. [2006.09]
A cost threshold analysis of ciprofloxacin-dexamethasone versus ofloxacin for acute otitis media in pediatric patients with tympanostomy tubes. [2004.07]
Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial. [2004.07]
Topical ofloxacin for chronic suppurative otitis media and acute exacerbation of chronic otitis media: optimum duration of treatment. [2003.05]
A benefit-risk assessment of ofloxacin otic solution in ear infection. [2003]
In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents. [2001.01]
Efficacy of ofloxacin and other otic preparations for otitis externa. [2001.01]
Safety of ofloxacin otic and other ototopical treatments in animal models and in humans. [2001.01]
Ofloxacin otic solution: a review of its use in the management of ear infections. [1999.09]
Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. [1999.05]
Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations. [1999.03]
Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media. [1998.07]
A preliminary report: clinical effects of otic solution of ofloxacin in infantile myringitis and chronic otitis media. [1998.01]
Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa. [1995.09]
The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study. [1995.01]
[Bacteriological evaluation of ofloxacin otic solution] [1992.10]
Other possibly related research studies
Differential penetration of ototopicals and water through tympanostomy tubes. [2005.08]
Opening plugged tympanostomy tubes: effect of inner diameter and shaft length. [2005.02]
Microbiology of otorrhea in children with tympanostomy tubes: implications for therapy. [2003.12]
A systematic review of the effectiveness of ofloxaxin otic solution for the treatment of suppurative otitis media. [2003.03]
[Clinical and bacteriology observation on intraoperation usage of tarivid otic solution in treatment of chronic otitis media with cholesteatoma] [1999.05]
Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections. [2002.10]
[Tympanostomy tube otorrhea: microbiological epidemiology, pathogen susceptibility to local antibiotics and bactericidal power of the rifamycin-olfloxacin combination] [2001.10]
Antimicrobial ear drop medication therapy. [1996]
Ototoxicity of topical otomicrobial agents. [1995.03]
In vitro activity of ototopical drops against middle ear pathogens. [1993.03]
Topical otic antibiotics: clinical cochlear ototoxicity and cost consideration. [2006.08]
An economic evaluation of two ototopical treatments for acute otitis media in tympanostomy tube patients. [2006.07]
Opening plugged tympanostomy tubes: effect of biofilm formation. [2006.01]
In vitro efficacy of the successive or staggered use of eardrops. [2006.05]
Improving the penetration of ototopicals through tympanostomy tubes: role of surfactants. [2008.01]
Assessing the efficacy of tragal pumping: a randomized controlled trial. [2011]
|
